Navigation Links
Mark Boguski, PhD, MD, Appointed to Role of Chief Medical Officer – Precision Medicine
Date:4/18/2017

Cancer diagnostics and pathology workflow solution provider Inspirata®, Inc. announced today that Dr. Mark Boguski has been appointed to the role of Chief Medical Officer (CMO) – Precision Medicine, overseeing strategic planning and implementation of Inspirata’s precision medicine solutions.

“Dr. Boguski is widely considered a visionary leader in precision medicine, and he has extensive experience in oncology, biomedical informatics, genomics, molecular profiling,” says Inspirata CEO Satish Sanan. “In his new role as CMO, Dr. Boguski will provide thought leadership as well as strategic direction to enable healthcare organizations to implement precision medicine programs, share information and optimize operations to improve clinical outcomes.”

Prior to joining Inspirata in September 2016, Dr. Boguski was the CMO and Co-founder of Precision Medicine Network, Inc., (PMNI), where he created a molecular oncology knowledge visualization and decision support platform, called “Crosswalk Insight™: Oncology.” A pathologist by training, Dr. Boguski envisioned Crosswalk empowering the oncology care team with the necessary molecular proficiency to support the widespread adoption of precision medicine.

Since its acquisition of PMNI, Inspirata has integrated the Crosswalk platform into its existing cancer diagnostic workflow solution and its pathology consultation portal. Crosswalk is used by healthcare professionals as well as patients to easily understand and communicate critical cancer information, associated molecular pathways, targeted therapies and clinical trials. Crosswalk is easily integrated within the existing healthcare IT environment and is also available on iOS and Android mobile devices and desktop systems.

During his distinguished career, Dr. Boguski has held faculty positions at Harvard Medical School, Johns Hopkins University School of Medicine, the National Institutes of Health and National Library of Medicine, and he has had executive positions in the biotechnology and pharmaceutical industries. He founded the Genomic Medicine Initiative at Beth Israel Deaconess Medical Center in Boston, and is an elected member of the U.S. National Academy of Medicine.

About Inspirata, Inc.
Inspirata®, Inc. offers the most comprehensive cancer diagnostics workflow solution available for precision diagnosis today. The solution, which employs a unique “solution-as-a-service” business and delivery model, accelerates anatomic and molecular pathology workflows and facilitates whole slide imaging and image analytics, prognostic and predictive assays, remote consultations and tumor boards. This comprehensive solution includes an Enterprise Service Bus (ESB) to help to solve interoperability issues and a Natural Language Processing Engine (NLP) for structuring data. Inspirata amalgamates this structured data into a central multi-institutional and multi-modal big data cancer repository for clinical, research and educational purposes. Its use will extend to physicians, patients, researchers and pharma among others. This comprehensive solution facilitates a modern precision diagnosis to build a strong foundation for precision medicine. For more information, please visit http://www.inspirata.com or contact info@inspirata.com.

Read the full story at http://www.prweb.com/releases/2017/04/prweb14241046.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. Former P&G VP Appointed New Industry Expert at Verixs Advisory Board
2. Gerard Morgan Appointed President of U.S. Technical Services Operation for DPS
3. Philip Goliber, PhD, Appointed Partner in Product Development and Regulatory Strategy Consulting Firm NDA Partners
4. Raymond H. Hill Appointed Chief Executive Officer and Chairman of the Board of Directors of Corrona Holdings
5. Novogen Announces Changes to the Board with New Chairman and Deputy Chairman Appointed
6. BHIs President and CEO Rich Bendis Appointed to Maryland Life Sciences Advisory Board
7. Stephen C. Farrell Appointed to STAAR Surgical Board of Directors
8. Newly Appointed Acting CEO Outlines Immediate Plans for Novogen
9. Alexandria Real Estate Equities, Inc. CEO Joel Marcus Appointed to BIO Board
10. Michel Seidelin Appointed Chief Commercial Officer as Biomatters Prepares to Release New Offerings
11. Luke M. Beshar Appointed to Fluorinov Pharma Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/22/2017)... ... June 22, 2017 , ... For the months of May ... Spotlight series on “Cell Therapy Regulation” for its regenerative medicine followship. ... the unique regulatory challenges of stem cell medical research. , Stem cell clinical ...
(Date:6/22/2017)... ... 2017 , ... Charm Sciences, Inc. is pleased to announce that its Charm ... appropriate as a screening test at dairies and farms for raw commingled cow milk. ... Charm EZ Lite system. These systems are a combination incubator and reader in one. ...
(Date:6/20/2017)...  Kibow Biotech Inc., a pioneer in developing "Enteric ... a new patent covering a unique method for preventing ... and Trademark Office on May 23 rd 2017. ... Bio award in 2014 in San Diego, ... to chronic disease. Renadyl™, the first and only dietary ...
(Date:6/19/2017)... ... 19, 2017 , ... As Vice President, Product Services, Mr. ... implementation, support, and client process and SOP development. , Mr. Guinter brings a ... roles for service providers and top-tier pharmaceuticals, and as an independent consultant supported ...
Breaking Biology Technology:
(Date:5/23/2017)... May 23, 2017  Hunova, the first robotic gym for the rehabilitation ... officially launched in Genoa, Italy . The first 30 ... and the USA . The technology was developed and ... by the IIT spin-off Movendo Technology thanks to a 10 million euro ... Release, please click: ...
(Date:4/19/2017)... New York , April 19, 2017 ... competitive, as its vendor landscape is marked by the ... the market is however held by five major players ... Safran. Together these companies accounted for nearly 61% of ... of the leading companies in the global military biometrics ...
(Date:4/11/2017)... , April 11, 2017 Crossmatch®, ... secure authentication solutions, today announced that it has ... Advanced Research Projects Activity (IARPA) to develop next-generation ... program. "Innovation has been a driving ... Thor program will allow us to innovate and ...
Breaking Biology News(10 mins):